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During  contact  activation  of plasma,  cleavage  of surface-bound  Hageman 
factor  (HF)  1 occurs at two closely situated  sites,  one within  a  disulfide  loop, 
termed  "site  1",  and  one  outside the  disulfide  loop,  termed  "site  2"  (1).  The 
result of these cleavages is two forms of active HF (2) which we have given the 
names  a-HF  a  and  fi-HFa.  Fig.  1  defines  these  two  forms  based  on  their 
derivation  (last  column)  and  molecular  characteristics  (first  four  columns). 
Although it is known that contact activation of plasma will result in coagulation 
(via the intrinsic  pathway),  flbrinolysis,  and kinin  generation,  a  quantitative 
comparison of the ability of each form of HF  a to initiate these systems has not 
been  made.  We therefore  undertook the  studies  reported  here to  investigate 
the relative ability of a-HF  a and fi-HF  a to activate the HF substrates, prekalli- 
krein  and  factor  XI,  in  plasma  during  contact  activation.  The  experiments 
were  performed  in  whole  plasma,  rather  than  with  purified  components,  to 
follow as  closely as  possible the  events  as  they  would occur during  contact 
activation of plasma.  It has been shown that  the cleavage of prekallikrein  is 
coincident with its activation by HF~ (3). 2 Activation of factor XI has also been 
shown to be associated with a  proteolytic cleavage of its 80,000  mol wt subunit 
chains  (3-5).  Thus,  by following  the  cleavage  of radiolabeled  prekallikrein 
and factor XI added to plasma,  we could measure their rate of activation. 
It  has  recently  been  reported  from  this  laboratory  that  during  contact 
activation,  a  large  percentage  of the  factor  XI  and  a  small  amount  of the 
prekallikrein  in  plasma  become surface  bound  (6).  We have  expanded  upon 
these observations by investigating the influence of the surface on the cleavage 
of factor  XI  and  prekallikrein  and  have  followed the  distribution  of these 
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FIG. i.  Characteristics  of  HF and its  activated  forms produced  during contact  activation 
of  plasma. Two forms of HF  a are defined by cleavage of  the native zymogen at specific 
sites.  The  biologic  activities  of  each  and  their  molecular  characteristics  are as indicated. 
proteins between the surface and fluid  phase compartments before and after 
their  interaction  with HF  a. 
Materials and Methods 
Plasmas.  Normal human plasma was pooled from 19 normal healthy adults  using 1/e vol of 
acid citrate dextrose as an anti-coagulant.  Plasma deficient in high molecular weight kininogen 
(HMWK, plasma of Mr. Fitzgerald) was obtained from George King Biomedical (Salem, N, H.). 
Plasma deficient in prekallikrein was supplied by Dr. Charles Abildgaard.  HF-deficient plasma 
was generously donated by Mrs. Gunda Hiatt. 
Preparation  and  Radiolabeling  of Proteins.  HF  and  factor  XI  were  isolated  from  human 
plasma as described elsewhere (7, 5). Isolation of prekallikrein was by methods similar to those 
utilized for factor XI purification  (5),  employing sequential chromatography  on DEAE-, QAE-, 
and  SP-Sephadex,  concanavalin  A-Sepharose,  and  a  final  separatory  step  of sucrose  density 
ultracentrifugation. 3 Each was judged to be greater than 95% homogeneous when analyzed by 
electrophoresis on polyacrylamide gels containing sodium dodecyl sulfate (SDS). HF having 80 ± 
15 clotting U/mg protein was radiolabeled without loss of functional activity with  ~2sI and  ~3~I 
using the solid state lactoperoxidase method (8). The 125I-HF contained 5.1-9.6/~Ci//~g (1.2 to 1.9 
/~Ci//~l) and the 131I-HF 9.5/~Ci//~g (0.57/~Ci//~l). Factor XI was radiolabeled by the same method 
(8)  with an uptake  of 9  /~Ci//~l.  After radiolabeling,  the factor XI contained 3.8  clotting U  of 
activity per ml. Prekallikrein,  having a  specific clotting activity of 19 U/rag, was radiolabeled 
with 125I by the chloramine T method of McConahey and Dixon (9). It contained 9.1 /~Ci//~g (0.29 
~Ci/~l). 
Contact Activation.  Whole plasma,  rather than isolated individual components,  was chosen 
as the  medium  for the experiments to  approximate  conditions under  which contact activation 
presumably occurs in vivo. In this way, not only the various components of the contact system 
would be present, but the inhibitors as well. The contact activation system used in these studies 
was chosen for its ability to provide a simple method of activating the enzymes of interest under 
conditions where  the  kinetics of activation could be followed and  special procedures,  such  as 
removal of supernates  and washing of surfaces,  could be easily and rapidly accomplished. The 
3  B. N. Bouma and J. H. Griffin.  1978.  Manuscript in  preparation. REVAK,  COCHRANE~  BOUMA,  AND  GRIFFIN  721 
method consisted of the addition of a radiolabeled protein to plasma, an appropriate dilution, and 
the incubation of a  sample in a  glass tube. The radiolabeled protein added did not increase the 
plasma content of that protein by more than 20%.  The plasma was diluted 1/6 in all experiments 
except,  as noted, where complete activation of HF was required,  in which case the dilution was 
1/25. The diluent employed  was Tris-buffered saline (0.01  M  Tris,  0.15  M  NaCl,  pH  7.6).  20-~1 
aliquots were placed in 12  ×  75 mm new, unwashed berosilicate glass tubes and shaken at room 
temperature for varying times. The procedure thereafter varied with the experiments and will be 
described in more detail below.  In general,  however,  after 5 rain of incubation, 50% of the HF 
was  activated,  with  approximately  equal  amounts  of  ~-HF  a  and  ~°HF  a  being  formed.  This 
corresponds to 0.04 pg HF  a per tube. Separation of the a- and E-forms of HF  a was accomplished 
by removal of the supernate from the tube.  ("Supernate" is used here to refer to the plasma in 
the  glass  tube after incubation.)  Previous reports  have shown that under these conditions of 
activation, a-HF  a will be surface bound and ~-HF  a will be found in the supernate (1,  2). 
SDS-Polyacrylamide Gel Electrophoresis.  Samples were prepared for electrophoresis by the 
addition of 50 pl of 4% SDS in 0.01 M sodium phosphate buffer pH 7.0 containing (except where 
noted)  2%  fl-mercaptoethanol.  After an  immediate 3  rain  incubation in  a  boiling water bath, 
sucrose was added to a  10% final concentration and a  trace of bromophenol blue was included to 
serve as a  tracking dye. Electrophoresis was carried out on 4.5  ×  80 mm 7% polyacrylamide gels 
containing 0.1% SDS according to the method of Weber and Osborn (10)  until the tracking dye 
was within 1 cm of the bottom of the tube.  The gels were then removed from the tubes,  sliced 
into  1.2-ram  sections  and  counted  for radioactivity  in  a  model  1195  Searle  Analytic  Gamma 
counter (Searle Analytic Inc., San Diego, Calif.). Greater than 90% of the radioactivity applied 
to the gels was recovered. 
Immunologic  Quantitation of Kallikrein.  Kallikrein was quantitated by the radial immuno- 
diffusion  technique  of  Mancini  et  al.  (11)  using  a  1/lo  dilution  of  goat  antiserum  against 
prekallikrein.  The  monospecific  antibody  was  produced  by  the  weekly  injection of 60-80  /~g 
purified human prekaUikrein in complete Freund's adjuvant (Dffco Laboratories, Detroit, Mich) 
into multiple subcutaneous sites on the back of a  1-yr old goat. Serum collected after the 4th wk 
gave  a  single  line  of  precipitation  against  normal  human  plasma  when  tested  in  double 
immunodiffusion tests and no line when tested against plasma deficient in prekallikrein. 
Buffer.  The buffer used for washing the surface-bound proteins was phosphate-buffered saline 
(0.01  M sodium phosphate, 0.15 M NaC1, pH 7.0). 
Results 
Cleavage  of Prekallikrein and Factor XI in Plasma During Contact Activa- 
tion.  The kinetics of cleavage of prekallikrein and factor XI during contact 
activation of plasma was determined for the  system to be  used throughout 
these  studies.  ~25I-prekallikrein  and  ~2~I-factor XI  were  added  to  separate 
samples of normal human plasma. A 1/6 dilution was made of the plasmas and 
20-/~1 samples of each were incubated in glass tubes for varying time periods. 
To stop the reactions and elute any surface-bound material, 50  /~1 of an SDS- 
mercaptoethanol solution was added. The extent of cleavage of the radiolabeled 
proteins was assessed by electrophoresis on SDS-polyacrylamide  gels. Prekalli- 
krein and factor XI, run under reducing conditions, both migrate as polypep- 
tides of approximately 80,000 tool wt.  Upon the exposure of plasma to glass, 
~SI-prekallikrein  is  cleaved  to  yield  primarily  a  47,000 mol  wt  fragment; 
presumably the remainder of the ~olecule is unlabeled by the procedure used. 
~25I-factor XI in plasma exposed to glass is cleaved into fragments of 47,000 and 
33,000 tool wt. Typical cleavage patterns for these two proteins are'shown in 
Fig. 2. HF of 80,000 tool wt and its 52,000 and 28,000 tool wt cleavage fragments 
were included in the gels as molecular weight standards for comparison. The 
percent of radiolabel in each gel which appeared at a  tool  wt of 80,000 was 
calculated. With the percent present in the 80,000 peak at a  zero time point 722  ACTIVITIES  OF  TWO  FORMS  OF  ACTIVATED  HAGEMAN  FACTOR 
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Fro.  2.  Analysis by  SDS-polyacrylamide gels of cleavage of 12SI-prekallikrein  and  125I- 
factor XI in plasma.  Samples of diluted normal plasma containing 13q-HF and either ~25I- 
prekallikrein  or 12sI-factor  XI were incubated  in glass tubes.  SDS-mercaptoethanol was 
added to the sample containing ~25I-prekallikrein after 2 min incubation and to the sample 
containing the 125I-factor XI after 5 min incubation.  The samples were then subjected to 
electrophoresis in 7% polyacrylamide gels containing 0.1%  SDS. The gels were sliced and 
counted for radioactivity.  Molecular weights are based on the known weights of the HF 
fragments. 
taken  as 100%,  the percent remaining  at 80,000  (i.e.,  percent uncleaved) was 
computed and, by subtracting this value from 100%, the data were expressed as 
percent of molecules cleaved. The kinetics of cleavage for l~SI-prekallikrein and 
l~sI-factor XI are shown in Fig. 3. 
Cleavage  of Surface-Bound Factor XI and Prekallikrein by Surface-Bou~zd 
a-HF  a.  To study cleavage of factor XI on a  surface by surface-bound a-HF  a, 
20-~1  aliquots of a  1/e dilution of normal plasma containing  ~2sI-factor XI were 
shaken in glass tubes. At the end of a  2 min incubation period, the supernate 
was removed and the tube washed three times with 200 ~1 buffer. Preliminary 
experiments  showed that  in  2  min  sufficient  HF became bound  and  cleaved 
(activated)  to  yield  measurable  rates  of factor  XI  cleavage.  This  incubation 
period was also sufficient to bind 62% of the  12~I-factor XI; 44%  of that  which 
was bound, was cleaved. 50 ~1 of an SDS-mercaptoethanol solution was added 
to one tube, thereafter called the 0 time sample. The remaining tubes received 
2  ml  of buffer  and  were  incubated  with  shaking  for  varying  times.  In  the 
presence of 2 ml of buffer, any  a-HFa which might elute off the surface, or 8- 
HF~ which was released, would become rapidly diluted (a minimum of 600-fold) 
and the probability of any interaction between them and surface-bound factor 
XI would be greatly diminished.  After the desired incubation times, the 2 ml of 
buffer was removed and 50/~1 of the SDS-mercaptoethanol solution was added. 
All samples were analyzed by SDS-polyacrylamide gel electrophoresis for the 
amount of cleavage of 125I-factor XI. The 0 time point was taken as 0% cleavage REVAK,  COCHRANE,  BOUMA,  AND  GRIFFIN 
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FIG. 3.  Cleavage of prekallikrein and factor Xl in plasma during contact activation. 
Samples of diluted normal plasma containing either 1~Sl-prekallikrein  or 125I-factor  XI 
were incubated in glass  tubes for varying times. SDS-mercaptoethanol was added to stop 
the reactions and the samples were analyzed by electrophoresis  on SDS-polyacrylamide 
gels for cleavage of  the 12~I-prekallikrein  and IssI-factor  XI. The percent of  prekallikrein 
and factor  XI cleaved was determined in both cases by the disappearance of  1251  from the 
80,000 tool  wt peak of  native material. 
(i.e.,  the 44% cleavage observed after  the initial  2 rain  incubation which could 
not be assumed to be due strictly  to surface reactions was subtracted). The 
results, shown as the dashed line in Fig. 4 indicate that signifcant cleavage 
occurs  over  a  20  rain time  period. Since  fluid phase  contributions  were 
minimized by dilution during the 20 rain  of  incubation, the observed cleavage 
was essentially  caused by the action of surface-bound a-HF  a on surface-bound 
factor  XI. 
Since prekallikrein binding to the surface is quite weak  (6), a different 
experimental system was employed to investigate its cleavage on the surface. 
125I-prekallikrein  was added to HF-deficient plasma. After a 1/6 dilution,  20-ftl 
aliquots were incubated in glass tubes for 5 rain,  the supernates removed, and 
the tubes washed three times with 200/~l buffer.  This procedure resulted in  the 
binding of 10% of the 1251-prekallikrein  and since HF-deficient plasma was 
used, no cleavage occurred during these 5 rain.  After the washing of  the bound 
]251-prekallikrein,  20 ftl of  a 1/6 dilution of  prekallikrein-deficient  plasma was 
added as a source of  HF to each tube for 20 s, diluted  out by the addition of  2 
ml buffer  which was then immediately removed and replaced with a fresh 2 ml 
of  buffer.  This step was designed to allow sufficient  HF to become bound to the 
surface and activated and then to remove all nonbound proteins and allow the 
incubation to proceed under conditions where any proteins being released from 
the surface would be prevented by dilution from entering into the cleavage 
reaction occurring on the surface. Timing was started from the moment  of 
addition of  the second 2 ml of  buffer.  At the end of  the desired incubation time, 
the buffer was removed and the surface-bound proteins eluted by the addition 
of SDS-mercaptoethanol. After analysis on SDS-polyacrylamide gels,  the per- 
cent of  ]251-prekallikrein  cleaved was determined. The results  are shown as  the 
solid  line  in Fig.  4. It is apparent that cleavage of  surface-bound prekallikrein 
by surface-bound a-HFa occurs very rapidly. As noted in the figure  legend, a 724  ACTIVITIES  OF  TWO  FORMS  OF  ACTIVATED  HAGEMAN  FACTOR 
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FIG.  4.  Cleavage of surface-bound factor XI and prekallikrein by surface-bound a-HF  a. 
Factor XI: samples of diluted normal plasma containing 12sI-factor XI were shaken in glass 
tubes. After 2 rain, the supernates were removed and the tubes washed. 2 ml of buffer was 
then added to each tube and, after varying incubation times, the surface-bound proteins 
were  eluted  with SDS-mercaptoethanol.  The  samples  were  analyzed by  SDS-pelyacryl- 
amide gel electrophoresis for the percent of ~2~I-factor XI cleaved (dashed line). Prekalli- 
krein: samples of diluted HF-deficient plasma containing 125I-prekallikrein were shaken in 
glass tubes for 5 rain, the supernates removed, and the tubes washed.  Samples of diluted 
prekallikrein-deficient plasma were then added to each tube, followed 20 s  later by 2 ml 
buffer. This buffer was then removed, a  fresh 2 ml buffer added, and the tubes incubated 
for varying times. The surface-bound proteins were eluted with SDS-mercaptoethanol and 
the  cleavage  of the  12SI-prekallikrein determined  by  SDS-pelyacrylamide  gel  analysis. 
Results  are  shown  as  the  solid  line.  Note  that  the  use  of two  different  experimental 
protocols prevent the direct comparison of the two sets of data shown in this figure. 
direct comparison of the rates of cleavage of the 125I-prekaUikrein and the 125I- 
factor XI shown in Fig.  4 cannot be made since different experimental  proce- 
dures were employed. 
The Action of ~-HFa on Surface-Bound Factor XI and Prekallikrein.  Prelim- 
inary experiments were performed to determine the dilution of plasma required 
to obtain complete binding of HF to glass and generate sufficient ~-HF  a in the 
supernate to yield measurable rates of cleavage of prekallikrein  and/or factor 
XI. The supernate of a  5 rain,  room temperature,  incubation in a  glass tube of 
20 ~l of a  1/25 dilution of normal plasma contained ~4% (0.0008  ~tg) native HF 
and  >82% of the ~-HF  a formed.  This corresponds to 0.0018  /~g of fl-HFa. This 
procedure was  used to  generate  ~-HF~ for the  experiments  described below: 
Cleavage of surface-bound factor XI by ~-HF~ was studied by using ~25I-factor 
XI added to HF-deficient plasma.  20 ~l of a 1/e dilution was allowed to incubate 
in glass for 5 rain with shaking  to allow maximal  binding of the factor XI to 
the surface.  After removal of the supernate and three buffer washes of 200 ~l 
each,  15  ~tl  of ~-HF~  was  added  to  each  tube.  The  tubes  were  allowed  to 
incubate with shaking for varying times before 50 ftl of SDS-mercaptoethanol 
solution  was  added  to  stop  the  reaction.  Cleavage  of the  ~25I-factor  XI  was 
assessed  by electrophoresis  on  SDS-  polyacrylamide  gels.  As  shown  by the 
dashed line in Fig. 5, no cleavage was observed over a  20 rain time period. 
An identical experiment was performed with ~25I-prekallikrein instead of 125I- 
factor XI to assess the cleavage of surface-bound prekallikrein  by fl-HF  a. The 
results,  shown as the  solid line  in  Fig.  5,  show a  significant  cleavage of 125I- 
prekallikrein  by ~-HF,.  The  prekallikrein  cleaved,  however,  may not  all be 
surface  bound.  As  will  be  shown  below,  some  of the  bound  prekallikrein 
molecules may dissociate from the surface during the activation period and be REVAK,  COCHRANE,  BOUMA,  AND  GRIFFIN 
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FxG.  5.  Cleavage  of surface-bound  factor  XI  and  prekallikrein  by  •-HFa.  Samples  of 
diluted  HF-deficient  plasma  containing  either  ~25I-factor  XI  or  ~zSI-prekallikrein  were 
shaken in glass tubes for 5 rain. The supernates  were removed and the tubes washed.  ,8- 
HF~  (see  text  for  details  of preparation)  was  then  added  to  each  tube.  After  varying 
incubation times, the reactions were stopped and the proteins eluted with SDS-mercapto- 
ethanol. Cleavage of the ~2~I-factor XI and ~2~I-prekallikrein was assessed by electrophoresis 
of the samples on SDS-polyacrylamide gels. 
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cleaved in  solution.  Thus we cannot be  certain  that  the  cleavage of  prekallikrein 
shown in Fig. 5 is strictly  the cleavage of  surface-bound prekallikrein or if  the 
cleavage of  dissociated  molecules in solution is also  represented. 
The Action of  ~-HF  a  on Factor  XI and Prekallikrein  in Solution.  Possible 
cleavage in solution of  factor  XI and prekallikrein by ~-HF  a was also  investi- 
gated. 15 /~I of/3-HF  a, obtained as noted above, were added to plastic  tubes 
containing 5 /~I of a 1/6 dilution of  HF-deficient plasma containing either x25I- 
factor  XI or 125I-prekallikrein.  The tubes were incubated for  varying periods of 
time and the reactions  stopped by  the  addition of  50/~l  of  SDS-mercaptoethanol. 
After SDS polyacrylamide gel analysis of  the samples, the percent of  radiola- 
beled protein  cleaved was  determined;  the results are shown  in  Fig. 6. 
Prekallikrein in solution could be cleaved by /~-HFa but no cleavage of  factor 
XI was observed. 
In a  similar experiment,  the ~-HFa solution was incubated for 5 min with 1 
mg of Sepharose beads containing  covalently bound 10/~g of either goat anti- 
human  HF  or  normal  goat  gamma  globulin  before the  addition  of the  125I- 
prekallikrein  in  HF-deficient  plasma.  Normal  cleavage  of prekallikrein  oc- 
curred  in  the  presence  of the control beads but no cleavage was seen in  the 
samples incubated  with beads containing  anti-HF.  This  experiment  confirms 
that the cleavage of prekallikrein is specifically caused by an active form of HF 
and not any other proteolytic enzymes which might be present. 
Dissociation  of HF, Factor XI, Prekallikrein  and Kallikrein from a  Glass 
Surface in the Presence of Plasma.  Wiggins et al. have recently reported that 
during contact activation,  approximately 60% of the HF, 80% of the factor XI, 
and 15% of the prekallikrein in plasma became surface bound (6). In conjunction 
with our studies of the activation of surface-bound factor XI and prekallikrein 
by the two forms of HF~, it was necessary to determine the kinetics of elution 
of these proteins from the surface.  The dissociation of surface-bound HF was 
first studied by using  HMWK-deficient plasma  to prevent  HF activation  (1). 
20-~1  aliquots  of a  1/8 dilution  of HMWK-deficient plasma  containing  125I-HF 
were incubated in glass tubes for 5 rain.  The supernates were removed and the 
tubes, containing those proteins which had become bound to the surface, were 726  ACTIVITIES  OF  TWO  FORMS  OF  ACTIVATED  HAGEMAN  FACTOR 
25- 
20- 
~'  15 
o,,. 
f 
J 
H  Prekaliiklei, 
o- -o Fact0T Xl 
---~, .....  ,- ....  7 ....  -?. 
5  10  15  20 
Incubation Time (Min) 
FIG. 6.  Cleavage of  factor  XI and prekallikrein in solution  by fi-HFa. Samples of fi-HFa 
(see text for details  of preparation) were added to plastic  tubes containing diluted HF- 
deficient plasma containing either ~251-factor  XI or 1251-prekallikrein.  After varying incu- 
bation times, the reactions were stopped by the addition of  SDS-mercaptoethanol  and the 
samples assayed for cleavage  of the radiolabeled proteins by electrophoresis on SDS- 
polyacrylamide  gels. 
rapidly washed with three successive washes of 200 ftl buffer. The dissociation 
of the 12SI-HF from the surface was monitored by adding 200 pl of a  1/6 dilution 
of HMWK-deficient plasma to each tube, incubating at room temperature with 
shaking,  and removing the supernates at varying times. Since no activation of 
HF  occurs  in  HMWK-deficient  plasma  during  the  time  periods  used,  the 
appearance of radiolabel in the supernates during the second incubation period 
represents  the dissociation  of native  125I-HF from the  surface.  Approximately 
half of the 125I-HF added to each tube became surface bound during the initial 5 
rain  incubation.  With  this  amount  being  considered  as  100%  bound  at  the 
beginning of the elution incubation, the percent remaining bound after various 
times is shown as the dashed line  in the top panel of Fig.  7.  To consider the 
possible  influence  of HMWK on  the  binding  and/or  elution  of HF from the 
surface,  the identical  experiment was performed using prekallikrein-deficient 
plasma  instead  of HMWK-deficient plasma.  Those results  are  shown  as  the 
solid line in the top panel of Fig. 7. The data indicate that, under the conditions 
employed, 25-50% of the HF became dissociated from the surface in 10 rain. 
Employing the  same experimental  conditions,  the  elution  of surface-bound 
factor  XI  was  studied  using  125I-factor XI  added  to  HF-deficient  plasma. 
Approximately  65-70%  of the  12~I-factor XI  initially  present  became  bound 
during  the  frst  5  rain  incubation  period.  The  results,  shown  in  the  center 
panel of Fig. 7, indicate a  very slow rate of dissociation for this molecule. 
Prekallikrein  elution was determined rin a  similar manner  again using HF- 
deficient plasma and  125I-prekallikrein.  In this case, however, only 10-15% of 
the  radiolabeled protein  became initially  bound and that  underwent  a  rapid 
and  extensive  elution  during  the  second  incubation  (Fig.  7,  bottom  panel). 
When normal,  rather than HF-deficient plasma was used, an almost identical 
elution  profile  was  obtained.  Since  most  of the  prekallikrein  is  cleaved  to 
kallikrein  under these conditions,  an approximately equal dissociation rate is 
obtained for the activated enzyme. 
It should be noted that in all of the experiments just described, the amount 
of a  specific protein found dissociated from the surface at any given time will 
vary with both the volume and protein concentration of the fluid phase. REVAK,  COCHRANE,  BOUMA,  AND  GRIFFIN 
100 ~k~.__ 
~"'~"--"  -  -o-  .....  .¢.  ~-  -  -o  Usio  i  HMWK 
50  Using Pr ekallik[ein. 
Deficient Plasma 
20~  .___.  osinD nF. 
Deficient  Plasma 
i lOO-~%.~.  • 
5ol Factor  XI 
/ 
100 '~rek 
50  •  altikrein 
20.  --  ;  T 
i  1'o  ;'s  ~'o 
Incubation Time  IMin ) 
FIG.  7.  The elution of surface-bound HF, factor XI, and prekallikrein with plasma. 20-~1 
samples of a  1/e dilution of HMWK-deficient and prekallikrein-deficient plasma containing 
125I-HF, HF-deficient plasma containing 125I-factor XI, and HF-deficient plasma containing 
125I-prekallikrein  were  incubated  in  glass  tubes  at  room  temperature  for  5  rain.  The 
supernates were then removed and the tubes rapidly washed with three washes of 200/~1 
buffer.  200  ~1 of a  1/6 dilution of the same plasma used for the first incubation was then 
added to each tube and incubation continued at room temperature.  Elution of the bound 
radiolabeled  proteins  was  followed  by  removing  the  supernates  at  various  times  and 
counting the radioactivity remaining in the tubes. 
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Dissociation of kallikrein from the surface was also studied using immuno- 
logic  techniques.  2  ml  of normal  human plasma  was  mixed  with  20  mg of 
kaolin in  a  plastic tube  for  15  min at 22°C to  allow maximum binding and 
activation of the prekallikrein. The mixture was centrifuged for 3 min and the 
supernate removed.  The  kaolin pellet was resuspended and washed for 30  s 
with 200  ~1 buffer and centrifuged for 2 min to reform a  pellet. This washing 
was rapidly repeated a  total of three times.  All washes were saved for later 
analysis.  The  washed  kaolin  pellet  was  then  subjected  to  four  successive 
elutions  each  consisting of a  30  s  incubation  with  200  ~1  of prekallikrein- 
deficient plasma diluted 1/2 followed by a  2 min centrifugation. Each elution 
supernate  was  removed  and  analyzed,  along  with  the  washes,  by  radial 
immunodiffusion for  the  amount  of  kallikrein  present.  Of  the  kallikrein 
remaining bound to the kaolin after the three buffer washes, 84%  was disso- 
ciated and recovered in the four brief incubations with plasma.  This agrees 
favorably with the rapid dissociation of ;25I-kallikrein reported above. 
Discussion 
The data reported here show that the two forms of active HF produced by 
contact  activation  of plasma  show  differences  in  their  ability  to  activate 
prekallikrein and factor XI.  These differences depend, in part,  upon whether 
the enzyme and the substrate are surface bound or in solution. It was found 
that surface-bound a-HF  a can cleave both prekallikrein and factor XI when 
they are surface bound,  fl-HFa, in solution, was found to cleave prekallikrein 
in  solution  or  on  a  surface  but  had  no  demonstrable  activity on  factor  XI 728  ACTIVITIES  OF  TWO  FORMS  OF  ACTIVATED  HAGEMAN  FACTOR 
whether  bound  or  in  solution.  These  activities,  along  with  the  structural 
characteristics and derivation of the activated forms are summarized in Fig. 1. 
The  finding  that  surface-bound  ~-HF  a  can  activate  both  substrates  when 
they also are surface bound implies that either the enzyme and the substrates 
initially  bind  to the  surface  in  adjacent  positions or that  at  least one of the 
reactants  can  change  its  location  on  the  surface.  The  latter  is  an  unlikely 
explanation  for  the  experiment  as  presented  since  the  presence  of a  large 
volume of buffer during  the  incubation period would result  in  at least a  600- 
fold dilution  of any protein eluting from the surface,  thus making  it unlikely 
that an eluted molecule would bind again. 
When the cleavage of the two substrates  in solution by fl-HFa was investi- 
gated,  the  fl-HFa was found to have  selective activity;  that  is,  prekallikrein 
was cleaved while factor XI was not (Fig.  6).  Even when the substrates were 
surface bound, fl-HF  a was found capable of cleaving only prekallikrein  (Fig. 5). 
It should be stressed that the observed failure of any factor XI to be cleaved by 
~-HF~ is contingent  upon the conditions of the experiment.  In other systems, 
with greater concentrations  of reactants,  it might  well be possible to demon- 
strate  some  cleavage  of factor  XI  by  fl-HF~.  The  present  study  does  show, 
however, that the very weak procoagulant activity often reported for the lower 
molecular  weight  form  of HF  a  as  compared  to  the  higher  molecular  weight 
form(s),  is  caused  by  its  poor  reactivity  with  factor  XI.  By  contrast,  this 
molecule is an excellent activator of prekallikrein.  The reasons for the ability 
of B-HF~ to react readily with prekallikrein but not with factor XI are unclear. 
Wiggins et al.  (6) have recently found that  80% of the factor XI in plasma, 
after contact activation,  is surface bound,  while only 20% of the kallikrein  is 
found on the surface.  Our studies support these findings.  The elution studies 
indicate that the association between prekallikrein and the surface is weak; of 
the  molecules surface bound at  a  given time  (zero time),  almost  80%  can be 
eluted within 5 min.  By contrast, factor XI was found to be firmly attached to 
the surface. 
The  observation  that  factor  XI  must  be  surface  bound  to  be  efficiently 
cleaved and that once cleaved the fragments remain surface bound (6) strongly 
suggest that the first two steps of the intrinsic coagulation system are localized 
events. The kinin-generating and fibrinolytic systems, however, can be initiated 
either locally by the cleavage of prekallikrein by surface-bound a-HFa or in the 
fluid phase by fi-HF  a.  In either case, kallikrein,  once formed, exists primarily 
in solution.  The data presented here suggest that in vivo the activities of the 
kinin-forming  and  fibrinolytic  systems  would  disseminate  rapidly  from  the 
initial  locus  of activation,  while  those  of the  contact  phase  of the  intrinsic 
clotting system would remain localized.  The significance of these observations 
in vivo will be appreciated in further experiments. 
Summary 
The  ability  of the  two forms of activated  Hageman  factor  (HF  a)  produced 
during contact activation of plasma to activate prekallikrein and factor XI was 
studied,  a-HF~, defined as an 80,000  mol wt two-chain enzyme which remains 
bound to the surface was capable of cleaving surface-bound prekallikrein  and 
factor  XI.  B-HF~,  a  28,000  mol  wt  single  chain  molecule,  released  from  the 
surface during contact activation was able to cleave prekallikrein  but showed REVAK,  COCHRANE,  BOUMA,  AND  GRIFFIN  729 
no activity on factor XI. Cleavage of prekallikrein by ~-HF  a occurred irrespec- 
tive of whether the  substrate was  surface-bound or in  solution.  Cleavage of 
factor XI occurred only when it was surface bound and only the a-form of HF  a 
was capable of this proteolytic action. Factor XI was found to remain bound to 
the  surface  while  prekallikrein  and  kallikrein  rapidly  dissociated  from  the 
surface  into  the  supernate.  These  findings  suggest  that  the  initiation  of 
intrinsic coagulation through the  activation of factor XI  is  a  localized event 
occurring at the site of contact activation and is the result of the action of a- 
HF  a. By contrast, kinin generation and fibrinolysis resulting from the formation 
of kallikrein can be initiated either at the site of contact activation, by a-HFa 
action,  or throughout the  plasma,  by  /3-HFa;  further dissemination of these 
activities  is  assured  by  the  rapid  dissociation  of kallikrein  itself from  the 
surface. 
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